Senators say they’ve reached deal on ACA insurer subsidies

Sens. Lamar Alexander, R-Tennessee and Patty Murray, D-Washington, have told reporters they’ve reached an agreement to fund the Affordable Care Act’s cost-sharing reduction subsidies to insurers which had been halted by President Donald Trump.

Alexander, the chairman of the Senate’s health committee, has been working with Murray, the committee’s ranking Democrat, on a deal which would involve guaranteeing funding for the subsidies, known as CSRs, for two years in exchange for states having additional “flexibility” on waiving certain ACA requirements.

This would involve allowing all ACA exchange customers, not just those under 30, to sign up for lower-premium, high-deductible catastrophic plans. Additionally, the language governing ACA waivers, known as 1332s, would change: Instead of being limited to changes which make insurance plans “as affordable as” existing exchange plans, states could approve plans which offer “comparable” affordability. HHS would be required to offer “model” waiver plans to speed up the approval process for states.

ABC News reported there would be an additional win for Democrats in the deal: $160 million to restore funding for outreach and navigator programs cut by Trump ahead of the upcoming open enrollment period.

A draft of the legislation obtained by Axios said there would be a mechanism to prevent insurance companies from profiting off premium increases requested when the CSRs were in doubt. State insurance regulators would need to certify with HHS that states will pass on CSR funds to enrollees or the federal government.

Senate Minority Leader Chuck Schumer, D-New York, said the agreement would “undo” what he calls “sabotage” of the ACA by the Trump administration and promised the deal would have “broad support” among his caucus. Trump himself indicated he’d support the deal during a press conference at the White House, calling it a “short-term solution.”

Hours later, however, he was more critical of CSRs in a speech to the conservative Heritage Foundation.

“While I commend the bipartisan work done by Senators Alexander and Murray—and I do commend it—I continue to believe Congress must find a solution to the Obamacare mess instead of providing bailouts to insurance companies,” he said.

The legislation may find opposition among more conservative Republicans on Capitol Hill, especially in the House. Rep. Mark Walker, R-North Carolina, indicated he’d oppose a deal he sees as “propping up” the ACA.

“The GOP should focus on repealing and replacing Obamacare, not trying to save it,” Walker said, according to POLITICO. “This bailout is unacceptable.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.